2-Chloro-6-fluoronitrobenzene

We are 2-Chloro-6-fluoronitrobenzene CAS:64182-61-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloro-6-fluoronitrobenzene
CAS.NO:64182-61-2
Synonyms:2-Chloro-6-fluoronitrobenzene
1-Chloro-3-fluoro-2-nitrobenzene
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 245.1±20.0 °C at 760 mmHg
Molecular Formula C6H3ClFNO2
Molecular Weight 175.545
Flash Point 102.0±21.8 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.555
 
Specification:
Appearance:Light yellow powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

2-Chloro-6-fluoronitrobenzene


Related News: Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.1-chloro-2-fluorobenzene CAS:348-51-6 If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said.2- (4- 溴苯 基) – 丙 二酸 -1,3- 二 乙酯 CAS:149506-35-4 We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.[dimetilamino- (1-oxidopiridin-1-ium-2-il) sulfanilmetilideno] -dimetilazanio, hexafluorofosfato CAS:212333-72-7 Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.

Related Products
Product Name
5-Methoxy-2-methyl-1H-indole View Details
CYASORB THT 4611 View Details
N-(2-Butylbenzofuran-5-yl)methanesulfonamide View Details
2-((2-Amino-4-nitrophenyl)amino)ethanol manufacturer 1-hexadecyl-3-methylimidazolium chloride manufacturer 3,5-Bis(trifluoromethyl)bromobenzene manufacturer 5-Chloro-1-Pentanol manufacturer N-Methyl-N-Cbz-D-alanine manufacturer